No results for ‘’
Zim Laboratories Ltd
₹114.50
(1.28%)
Wed, 17 Jun 2026, 07:13 am
Health Technology
Pharmaceuticals: Generic
24.5KZim Laboratories Ratios
| Particulars | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 0 | 0 | 13.25 | 27.55 | 16.08 | 17.84 | 14.44 | 26.98 | 32.12 |
| Price to book ratio | 0 | 0 | 0 | 1.34 | 0.59 | 0.73 | 1.48 | 1.76 | 1.95 | 1.55 |
| Price to sales ratio | 0 | 0 | 0 | 0.62 | 0.33 | 0.39 | 0.79 | 0.89 | 1.28 | 1.04 |
| Price to cash flow ratio | 0 | 0 | 0 | 8.16 | 10.79 | 5.35 | 6.26 | 11 | 52.80 | 13.52 |
| Enterprise value | 0 | 0 | 0 | 277Cr | 179Cr | 192Cr | 308Cr | 407Cr | 567Cr | 506Cr |
| Enterprise value to EBITDA ratio | 0 | 0 | 0 | 8.20 | 9.77 | 6.97 | 8 | 8.39 | 15.43 | 12.60 |
| Debt to equity ratio | 0.98 | 0.68 | 0.59 | 0.51 | 0.60 | 0.51 | 0.30 | 0.31 | 0.47 | 0.47 |
| Return on equity % | 0 | 17.16 | 15.01 | 10.66 | 2.16 | 4.65 | 8.65 | 13 | 7.86 | 4.96 |
Zim Laboratories Ltd Ratios
The Zim Laboratories Ltd Ratios page provides a complete fundamental analysis of Zim Laboratories Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Zim Laboratories Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.
Zim Laboratories Ltd (NSE: ZIMLAB, BSE: 541400) is currently trading at ₹114.50, with a market capitalization of ₹581.54Cr. As a major player in the Health technology sector and Pharmaceuticals: generic industry, Zim Laboratories Ltd remains a key stock for fundamental analysis using Zim Laboratories Ltd Ratios.
Zim Laboratories Ltd Ratios: Valuation Overview
Price to Earnings Ratio (P/E)
The Zim Laboratories Ltd P/E ratio currently stands at 32.12, making it one of the most tracked metrics in Zim Laboratories Ltd Ratios.
Historically, the Zim Laboratories Ltd P/E ratio has shown strong fluctuations:
- 2024: 32.12
- 2023: 26.98
- 2022: 14.44
- 2021: 17.84
- 2020: 16.08
The rising Zim Laboratories Ltd P/E ratio indicates increasing investor confidence and premium valuation.
Price to Book Ratio (P/B)
The Zim Laboratories Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 1.55.
Historical P/B trend:
- 2024: 1.55
- 2023: 1.95
- 2022: 1.76
- 2021: 1.48
Zim Laboratories Ltd shows reasonable valuation compared to its asset base.
Price to Sales Ratio (P/S)
The Zim Laboratories Ltd P/S ratio currently stands at 1.04, an important part of Zim Laboratories Ltd Ratios for revenue valuation.
Historical P/S ratio:
- 2024: 1.04
- 2023: 1.28
- 2022: 0.89
- 2021: 0.79
A stable or declining Zim Laboratories Ltd P/S ratio indicates cautious market sentiment.
Zim Laboratories Ltd Price to Cash Flow Ratio (P/CF)
The Zim Laboratories Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 13.52.
Historical Zim Laboratories Ltd Price to Cash Flow Ratio:
- 2024: 13.52
- 2023: 52.80
- 2022: 11
- 2021: 6.26
- 2020: 5.35
The declining Zim Laboratories Ltd Price to Cash Flow Ratio suggests improving cash flow strength.
Zim Laboratories Ltd Enterprise Value Ratios
Enterprise Value (EV)
The Zim Laboratories Ltd EV currently stands at ₹506Cr, representing the total company valuation including debt.
Historical EV trend:
- 2024: 506Cr
- 2023: 567Cr
- 2022: 407Cr
- 2021: 308Cr
Zim Laboratories Ltd enterprise value consolidation suggests stable valuation.
EV/EBITDA Ratio
The Zim Laboratories Ltd EV/EBITDA ratio is currently 12.60, a key metric in Zim Laboratories Ltd Ratios to assess valuation relative to earnings.
Historical EV/EBITDA:
- 2024: 12.60
- 2023: 15.43
- 2022: 8.39
- 2021: 8
Stable Zim Laboratories Ltd EV/EBITDA indicates balanced valuation.
Zim Laboratories Ltd Financial Strength Ratios
Debt to Equity Ratio (D/E)
The Zim Laboratories Ltd D/E ratio is currently 0.47, reflecting leverage and financial stability.
Historical D/E:
- 2024: 0.47
- 2023: 0.47
- 2022: 0.31
- 2021: 0.30
Zim Laboratories Ltd maintains a strong balance sheet with low debt levels.
Return on Equity (ROE %)
The Zim Laboratories Ltd ROE currently stands at 4.96%, showing profitability and capital efficiency.
Historical ROE:
- 2024: 4.96
- 2023: 7.86
- 2022: 13
- 2021: 8.65
Declining ROE indicates pressure on profitability.
Zim Laboratories Ltd Ratios Analysis Summary
The Zim Laboratories Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Zim Laboratories Ltd stock is undervalued, fairly valued, or overvalued.
Tracking Zim Laboratories Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.